221 related articles for article (PubMed ID: 19164811)
21. Association of Plasma Pentraxin-3 Level with Lipid Levels and Cardiovascular Risk Factors in People with No History of Lipid-Lowering Medication: the Dong-gu Study.
Lee R; Ahn HR; Shin MH; Kim HN; Lee YH; Choi SW; Kweon SS
J Atheroscler Thromb; 2019 Aug; 26(8):738-745. PubMed ID: 30674758
[TBL] [Abstract][Full Text] [Related]
22. Soluble intracellular adhesion molecule-1 is associated with cardiovascular disease risk and mortality in older adults.
Jenny NS; Arnold AM; Kuller LH; Sharrett AR; Fried LP; Psaty BM; Tracy RP
J Thromb Haemost; 2006 Jan; 4(1):107-13. PubMed ID: 16409459
[TBL] [Abstract][Full Text] [Related]
23. Pentraxin 3 is a local inflammatory marker in atrial fibrillation.
Soeki T; Bando S; Uematsu E; Matsuura T; Niki T; Ise T; Kusunose K; Hotchi J; Ueda Y; Tomita N; Yamaguchi K; Yagi S; Fukuda D; Taketani Y; Iwase T; Yamada H; Wakatsuki T; Shimabukuro M; Sata M
Heart Vessels; 2014 Sep; 29(5):653-8. PubMed ID: 23979265
[TBL] [Abstract][Full Text] [Related]
24. Low circulating pentraxin 3 levels in pregnancy is associated with gestational diabetes and increased apoB/apoA ratio: a 5-year follow-up study.
Lekva T; Michelsen AE; Bollerslev J; Norwitz ER; Aukrust P; Henriksen T; Ueland T
Cardiovasc Diabetol; 2016 Feb; 15():23. PubMed ID: 26842615
[TBL] [Abstract][Full Text] [Related]
25. Pentraxin 3 (PTX3) plasma levels and carotid intima media thickness progression in the general population.
Baragetti A; Knoflach M; Cuccovillo I; Grigore L; Casula M; Garlaschelli K; Mantovani A; Wick G; Kiechl S; Willeit J; Bottazzi B; Catapano AL; Norata GD
Nutr Metab Cardiovasc Dis; 2014 May; 24(5):518-23. PubMed ID: 24462365
[TBL] [Abstract][Full Text] [Related]
26. Inflammation biomarkers and near-term death in older men.
Jenny NS; Yanez ND; Psaty BM; Kuller LH; Hirsch CH; Tracy RP
Am J Epidemiol; 2007 Mar; 165(6):684-95. PubMed ID: 17215383
[TBL] [Abstract][Full Text] [Related]
27. Incremental prognostic significance of the elevated levels of pentraxin 3 in patients with heart failure with normal left ventricular ejection fraction.
Matsubara J; Sugiyama S; Nozaki T; Akiyama E; Matsuzawa Y; Kurokawa H; Maeda H; Fujisue K; Sugamura K; Yamamoto E; Matsui K; Jinnouchi H; Ogawa H
J Am Heart Assoc; 2014 Jul; 3(4):. PubMed ID: 25012287
[TBL] [Abstract][Full Text] [Related]
28. Plasma pentraxin 3 may be a more sensitive marker of inflammatory response than high-sensitivity C-reactive protein after bare-metal stent compared to drug-eluting stent implantation.
Hudzik B; Szkodzinski J; Pietka-Rzycka A; Danikiewicz A; Wojnar R; Lekston A; Polonski L; Zubelewicz-Szkodzinska B
J Interferon Cytokine Res; 2013 May; 33(5):280-4. PubMed ID: 23414296
[TBL] [Abstract][Full Text] [Related]
29. Associations of plasma pentraxin 3 and monocyte chemoattractant protein-1 concentrations with cardiovascular disease in patients with chronic kidney disease.
Nishi K; Imamura T; Kitamura K; Ogawa T; Fujimoto S; Kakitsubata Y; Ishikawa T; Asada Y; Kodama T
Ren Fail; 2011; 33(4):398-404. PubMed ID: 21529268
[TBL] [Abstract][Full Text] [Related]
30. Inflammation and hemostasis biomarkers and cardiovascular risk in the elderly: the Cardiovascular Health Study.
Zakai NA; Katz R; Jenny NS; Psaty BM; Reiner AP; Schwartz SM; Cushman M
J Thromb Haemost; 2007 Jun; 5(6):1128-35. PubMed ID: 17388967
[TBL] [Abstract][Full Text] [Related]
31. Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) and risk of cardiovascular disease in older adults: results from the Cardiovascular Health Study.
Jenny NS; Solomon C; Cushman M; Tracy RP; Nelson JJ; Psaty BM; Furberg CD
Atherosclerosis; 2010 Apr; 209(2):528-32. PubMed ID: 19804884
[TBL] [Abstract][Full Text] [Related]
32. Cumulative Exposure to High-Sensitivity C-Reactive Protein Predicts the Risk of Cardiovascular Disease.
Wang A; Liu J; Li C; Gao J; Li X; Chen S; Wu S; Ding H; Fan H; Hou S
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29066453
[TBL] [Abstract][Full Text] [Related]
33. Elevated concentrations of pentraxin 3 are associated with coronary plaque vulnerability.
Soeki T; Niki T; Kusunose K; Bando S; Hirata Y; Tomita N; Yamaguchi K; Koshiba K; Yagi S; Taketani Y; Iwase T; Yamada H; Wakatsuki T; Akaike M; Sata M
J Cardiol; 2011 Sep; 58(2):151-7. PubMed ID: 21676590
[TBL] [Abstract][Full Text] [Related]
34. Oxidative Stress and Inflammatory Markers PTX3, CypA, and HB-EGF: How Are They Linked in Patients With STEMI?
Dejanović VV; Stevuljević JK; Vukašinović A; Miljković M; Kafedzic S; Zdravković M; Ilić I; Hinić S; Cerović M; Stefanović M; Spasojević-Kalimanovska V; Memon L; Nešković AN; Bogavac-Stanojević N
Angiology; 2020 Sep; 71(8):713-720. PubMed ID: 32372694
[TBL] [Abstract][Full Text] [Related]
35. Elevated levels of the long pentraxin 3 in paracetamol-induced human acute liver injury.
Craig DG; Lee P; Pryde EA; Walker SW; Beckett GJ; Hayes PC; Simpson KJ
Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):359-67. PubMed ID: 23169308
[TBL] [Abstract][Full Text] [Related]
36. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project.
Tracy RP; Lemaitre RN; Psaty BM; Ives DG; Evans RW; Cushman M; Meilahn EN; Kuller LH
Arterioscler Thromb Vasc Biol; 1997 Jun; 17(6):1121-7. PubMed ID: 9194763
[TBL] [Abstract][Full Text] [Related]
37. Increased serum pentraxin-3 level predicts poor prognosis in patients with colorectal cancer after curative surgery, a cohort study.
Liu B; Zhao Y; Guo L
Medicine (Baltimore); 2018 Oct; 97(40):e11780. PubMed ID: 30290589
[TBL] [Abstract][Full Text] [Related]
38. Pentraxin 3 in the assessment of ventilator-associated pneumonia: an early marker of severity.
Lin Q; Fu F; Shen L; Zhu B
Heart Lung; 2013; 42(2):139-45. PubMed ID: 23273657
[TBL] [Abstract][Full Text] [Related]
39. Serum pentraxin-3 and tumor necrosis factor-like weak inducer of apoptosis (TWEAK) predict severity of infections in acute decompensated cirrhotic patients.
Fan WC; Huang CC; Yang YY; Lin A; Lee KC; Hsieh YC; Fung CP; Hsu HC; Hou MC; Lin HC
J Microbiol Immunol Infect; 2017 Dec; 50(6):905-914. PubMed ID: 26872435
[TBL] [Abstract][Full Text] [Related]
40. Low-grade inflammation as a risk factor for cardiovascular events and all-cause mortality in patients with type 2 diabetes.
Sharif S; Van der Graaf Y; Cramer MJ; Kapelle LJ; de Borst GJ; Visseren FLJ; Westerink J;
Cardiovasc Diabetol; 2021 Nov; 20(1):220. PubMed ID: 34753497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
